Akari Therapeutics (AKTX) Prepaid Assets (2014 - 2026)

Akari Therapeutics (AKTX) posted quarterly Prepaid Assets of $731000.0 for Q1 2026, up 16.59% year-on-year from $627000.0 in Q1 2025, and up 295.14% on a QoQ basis from $185000.0 in Q4 2025.

Akari Therapeutics (AKTX) Prepaid Assets (2014 - 2026) Analysis & Trends

Akari Therapeutics (AKTX) has reported Prepaid Assets for 13 consecutive years, with $731000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Prepaid Assets rose 16.59% year-over-year to $731000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $731000.0 (up 16.59% YoY) and the FY2025 annual result came in at $185000.0, down 7.96% from the prior year.
  • Prepaid Assets climbed to $731000.0 in Q1 2026 per AKTX's latest filing, from $185000.0 in the prior quarter.
  • Over the last five years, Prepaid Assets for AKTX reached as high as $3.1 million in Q2 2022 and fell as low as $185000.0 in Q4 2025.
  • A 5-year average of $726987.4 and a median of $465000.0 in 2022 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2022 — Prepaid Assets jumped 204.79% — and 2023, when it tumbled 79.59%.
  • Year by year, Prepaid Assets stood at $465000.0 in 2022, then sank by 35.7% to $299000.0 in 2023, then slumped by 32.78% to $201000.0 in 2024, then slipped by 7.96% to $185000.0 in 2025, then jumped by 295.14% to $731000.0 in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $731000.0, $185000.0, and $349000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Akari Therapeutics 86.55 Mn 86.55 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 731,000.00
Dec 31, 2025 185,000.00
Sep 30, 2025 349,000.00
Jun 30, 2025 447,000.00
Mar 31, 2025 627,000.00
Dec 31, 2024 201,000.00
Sep 30, 2024 396,000.00
Jun 30, 2024 805,000.00
Mar 31, 2024 1.23 Mn
Dec 31, 2023 299,000.00
Jun 30, 2023 629,938.00
Dec 31, 2022 465,000.00
Jun 30, 2022 3.09 Mn
Dec 31, 2021 2.17 Mn
Jun 30, 2021 1.01 Mn
Dec 31, 2020 292,680.00
Sep 30, 2020 1.35 Mn
Jun 30, 2020 1.68 Mn
Mar 31, 2020 1.83 Mn
Dec 31, 2019 712,975.00